Exhibit 10.8


 





	 

                            
	Arconic
 201 Isabella Street
 Pittsburgh, PA 15212-5858

                            

                           Tim Myers
 EVP & Group 
 President Global
 Rolled Products, 
 Extrusion, and 
 Building & 
 Construction Systems




 


 


January 29, 2020


 


Erick Asmussen


200 Morning Mist Lane


Franklin, TN 37064


 


Dear Erick:


 


As we have discussed, on behalf of Arconic Inc. (the “Company”),
I am pleased to offer you the position of Executive Vice President & Chief Financial Officer Designate of Arconic Corporation
based in Pittsburgh, PA and reporting directly to me. You will become Executive Vice President & Chief Financial Officer of
Arconic Corporation upon the legal separation of Arconic Corporation from Arconic Inc. (such separation, the “Spinoff,”
and the date of such separation, “Legal Day 1”), and, from and after the Spinoff, references herein to the Company
shall be deemed to refer to Arconic Corporation, unless the context clearly indicates otherwise.


 


During your employment with the Company, you will devote substantially
all of your working time and attention to the business and affairs of the Company (excluding any vacation to which you are entitled)
and you will comply with the Company’s policies and rules, as in effect from time to time.


 


Set forth below is your total compensation package, together
with other important information.


 


Base Salary:


 


Your annual base salary will initially be $530,000 paid on a
monthly basis in accordance with the Company’s normal payroll practices, and subject to all applicable taxes and withholdings.


 


Incentive Compensation:


 


You will initially be eligible for a target annual cash incentive
compensation opportunity of 85% of your base salary (i.e., $450,500 based on your initial base salary) for a full year, if individual
and business performance targets are met. Actual payouts could be higher or lower than target depending on individual and business
performance. Your annual cash incentive compensation opportunity and award for 2020 will also be prorated to reflect the portion
of the year that you are employed with the Company.


 






     


     


    

 


Equity Compensation:


 


You will be eligible for annual equity compensation awards in
connection with the Company’s regular annual grant cycles.  Your first such award will be granted on the date that the
Company makes its 2020 annual equity awards grants to Company executives generally, which is anticipated to be within the first
month after Legal Day 1, and will consist of (i) a restricted share unit award with a grant date value of $380,000, which will
vest on the third anniversary of the grant date, subject to your continued employment with the Company through such date and (ii)
a performance-based restricted share unit award with a grant date value (at target) of $570,000, which will be subject to performance
goals applicable to Arconic Corporation, as well as to your continued employment with the Company through the third anniversary
of the grant date (together, the “RSUs”).


 


For each subsequent calendar year (starting in 2021) in which
you are employed by the Company, you shall be eligible to receive additional grants of equity-based and other long-term incentives
offered to senior executives generally, at a level, and on terms and conditions, that are commensurate with your positions and
responsibilities at the Company, and appropriate in light of your performance and of corresponding awards (if any) to other senior
executives of the Company (in all cases, as determined in good faith by the Board or a committee thereof).


 


Equity Ownership Requirements:


 


Consistent with Arconic Inc.’s efforts to align the interests
of its senior leadership with the interests of Arconic shareholders, Arconic Inc. has adopted equity ownership requirements for
senior Arconic Inc. executives and it is anticipated that Arconic Corporation will adopt similar requirements. You will be subject
to these requirements, currently 3.0 times base salary for the Executive Vice President & Chief Financial Officer, during your
employment with the Company. Until equity ownership requirements are met, you are required to retain 50% of shares acquired upon
vesting of restricted stock units and performance-based restricted stock units or upon exercise of stock options, after deducting
those used to pay for applicable taxes and/or the exercise price.


 


Relocation:


 


No later than September 30, 2020, you will relocate and establish
a permanent residence in the Pittsburgh, PA metropolitan area. The Company provides a Transfer and Relocation Plan, the terms of
which are determined by the Company in its discretion from time to time, to help facilitate your permanent relocation. Should you
voluntarily elect to leave Arconic in the first 24 months of employment (other than your voluntary termination within 30 days after
August 1, 2020 if the Spinoff has not occurred by July 31, 2020), you agree to reimburse the company for the cost incurred for
the Transfer and Relocation Plan. Details of this Plan will be sent to you separately.


 


Benefits:


 


During your employment with the Company, you will be eligible
to participate in Company benefit plans as in effect from time to time on the terms applicable to Company senior executives generally
(subject to the applicable eligibility and other requirements set forth therein), including health care, life insurance, and disability
coverage.


 


You will be eligible for the Company’s Executive Preventative
Health Evaluation Program. Since you play such a vital role within the Company and your well-being is important to the Company’s
success, the Company has established this program to help protect your health through regular health evaluations. All costs
of regular evaluations are fully paid by the Company.


 






    	 	 A-2	 



     


    

 


Retirement Savings Plan:


 


The Company offers a tax qualified 401(k) savings plan and a
non-qualified deferred compensation plan to help you save toward retirement. Current Company contributions are:


 


		·	3% of your base salary and incentive compensation, and



		·	a match of your deferred pre-tax savings dollar-for-dollar up to 6%
of your base pay. 



 


Company contributions in excess of IRS limits will be made to
the non-qualified deferred compensation plan.


 


Vacation:


 


During your employment
with the Company, you will be entitled to such vacation benefits as are available to similarly situated Company senior executives
from time to time (but not less than four (4) weeks per year), in addition to Company-recognized holidays.


 


Confidentiality, Developments, Non-Competition
and Non-Solicitation Agreement:


 


In consideration of your employment with
the Company, you agree to execute the Confidentiality, Developments, Non-Competition and Non-Solicitation Agreement attached hereto
as Annex A.


 


Severance:


 


You will be designated as a Tier II Employee under each of the
Company’s Executive Severance Plan and Change in Control Severance Plan (together, the “Severance Plans”) and
you will participate at the same level under the corresponding plans anticipated to be adopted by Arconic Corporation (it being
understood that following the Spinoff, references in this letter to the Severance Plans or either Severance Plan shall be deemed
to refer to such corresponding plans of Arconic Corporation).


 


Notwithstanding the foregoing or any other notice requirements,
if the Spinoff has not occurred by July 31, 2020, you and we agree that (i) you will cease to be a participant in the Severance
Plans as of such date, and (ii) either you or the Company may, during the 30-day period commencing on August 1, 2020, terminate
your employment without advance notice, in which case (unless such termination is by the Company under circumstances that would
have constituted Cause under the Company’s Executive Severance Plan), subject to your executing a general release of claims
in favor of the Company and its affiliates in a form similar to the form of release required under the Severance Plans (as modified
by this letter) and such release becoming effective and irrevocable no later than the date that is 60 days following the date of
termination, the Company will make a lump sum payment to you on the 60th day following such date of termination equal to the product
of (x) 1.0 multiplied by (y) the sum of your annual base salary and your target annual bonus.


 


Indemnification:


You will be covered as an insured officer
under the Company’s director and officer liability insurance policy, as in effect from time to time, to the same extent,
and on the same terms, as other executive officers of the Company, and the Company will indemnify you (and advance expenses) to
the fullest extent permitted by the Bylaws of the Company and the General Corporation Law of the State of Delaware.


 






    	 	 A-3	 



     


    

 


Section 409A:


 


The payments and benefits provided under
this letter are intended to comply with, or be exempt from, the requirements of Section 409A of the Internal Revenue Code of 1986,
as amended, and the provisions of this letter shall be interpreted and applied consistently with such intent. All reimbursements
under this letter that constitute deferred compensation within the meaning of Section 409A will be made or provided in accordance
with the requirements of Section 409A, including, without limitation, that (i) in no event will any reimbursement payments be made
later than the end of the calendar year next following the calendar year in which the applicable expenses were incurred; (ii) the
amount of reimbursement payments that the Company is obligated to pay in any given calendar year shall not affect the amount of
reimbursement payments that the Company is obligated to pay in any other calendar year; and (iii) your right to have the Company
pay such reimbursements may not be liquidated or exchanged for any other benefit.


 


Miscellaneous:


 


Your employment with the Company will at
all times be at-will. Subject to your rights to the payments and benefits upon certain termination of employment in accordance
with the terms of the Executive Severance Plan and the Change in Control Severance Plan, in each case, as in effect from time to
time (and subject to the terms set forth above with respect to your ceasing participation in such plans if the Spinoff has not
occurred as of July 31, 2020), and this letter, nothing herein will confer upon you any right to continue in the employment of
the Company for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company or
you to terminate your employment at any time and for any reason, with or without cause. Upon your termination of employment for
any reason and as a condition to any payments and benefits to which you may become entitled under the Company’s Executive
Severance Plan, Change in Control Severance Plan, or this letter, at the request of the Board you will immediately resign your
position as an officer of the Company and all offices and directorships of all subsidiaries and affiliates of the Company. Any
waiver of any breach of this letter shall not be construed to be a continuing waiver or consent to any subsequent breach on the
part of either you or the Company. All payments hereunder shall be subject to applicable tax withholding.


 


Successors:


 


This Agreement shall be assigned to Arconic
Corporation, effective Legal Day 1. Other than Arconic Inc.’s assignment of this Agreement to Arconic Corporation on Legal
Day 1, neither party hereto may assign any rights or delegate any duties under this letter without the prior written consent of
the other party; provided, however, that this letter shall inure to the benefit of and be binding upon the successors and assigns
of the Company upon any sale of all or substantially all of the Company’s assets, or upon any merger, consolidation or reorganization
of the Company with or into any other corporation, all as though such successors and assigns of the Company and their respective
successors and assigns were the Company.


 


Entire Agreement:


 


Except as otherwise contemplated herein,
this letter contains the entire agreement between you and the Company with respect to the subject matter hereof. No modification
or termination of this letter may be made orally, but must be made in writing and signed by you and the Company.


 


Governing Law; Jurisdiction:


 


This letter will be governed and interpreted
in accordance with the laws of the State of Delaware without reference to its choice of law principles. Any action arising out
of or related to this letter will be brought in the state or federal courts with jurisdiction in Delaware, and you and the Company
consent to the jurisdiction and venue of such courts.


 






    	 	 A-4	 



     


    

 


This offer is contingent upon the following conditions:


 


		v	Your successful completion of a pre-employment drug screen. 



		v	Providing authorization and release for the Company to conduct a comprehensive
review of your background, the result of which is satisfactory to the Company. The authorization and release will also be valid
for subsequent reports during your period of employment with the Company. 



		v	Providing us with documentation in the original form establishing
both your identity and your employment eligibility in the U.S. 



		v	Signing the attached Confidentiality, Developments, Non-Competition
and Non-Solicitation Agreement. 



		v	Your truthful representation that you are not subject or party to
any agreement, understanding or undertaking, including any restrictive covenant with any prior employer, that would prohibit or
restrict you from accepting the position of Executive Vice President & Chief Financial Officer Designate of Arconic Corporation
or Executive Vice President & Chief Financial Officer of Arconic Corporation or from performing your duties with the Company.




		v	Your availability to commence employment with the Company no later
than February 17, 2020.



 


[Signature page follows.]


 






    	 	 A-5	 



     


    

 


To accept our offer, please sign and date the bottom of this
letter and return it to me by February 4, 2020. If you have any questions, please feel free to call me.


 


I look forward to officially welcoming you to the Company.


 


Best Regards,


/s/ Melissa Miller


Tim Myers (Melissa Miller on behalf of
T. Myers)


EVP & Group President Arconic Global Rolled Products, Extrusions
and Building and Construction Systems


 


 


cc:Neil Marchuk, Melissa Miller


 


 


Attachments: 


Confidentiality, Developments, Non-Competition and Non-Solicitation
Agreement


 


 


 


 




I, Erick Asmussen, am pleased to accept your offer of employment
dated January 29, 2020, for the position of Executive Vice President & Chief Financial Officer Designate in the terms detailed
in the offer letter.


 


 


 


	Accepted by:	 	Date:	 
	 	 	 	 
	 	 	 	 
	/s/
    Erick Asmussen	 	1/31/20	 
	Erick Asmussen	 	 	 




 






    	 	 A-6	 



     


    

 





SENSITIVE




 





Exhibit A


 


Confidentiality, Developments, Non-Competition,
and Non-Solicitation Agreement


 


As an employee of Arconic
Inc. (“Arconic”) or one of its subsidiaries (Arconic collectively with its subsidiaries, the “Company”),
you (“you” or “Employee”) will have access to or may develop confidential and proprietary information (as
defined below) of the Company. Therefore, in consideration of your employment, and recognizing the highly competitive nature of
the Company’s business, you enter into this Confidentiality, Non-Competition, and Non-Solicitation Agreement (this “Agreement”)
intending to be legally bound.


 


Confidentiality


 


You acknowledge that,
as an employee of the Company, you have access, and are privy, to information which is confidential and proprietary to the Company
and which is not generally available to the public from sources outside of the Company.


 


You agree to regard
and preserve as confidential any and all Confidential Information pertaining to the Company’s operations and affairs and
all information which is either learned or obtained by you during your employment, and which you know, or have reason to believe,
includes Confidential Information. You agree that you will use Confidential Information only for the performance of your duties
for the Company and you agree not to disclose any Confidential Information you acquire, except as expressly permitted below. You
understand and agree that this obligation of confidentiality shall continue indefinitely following the termination of your employment
with the Company.


 


Nothing in this Agreement
shall prohibit or restrict you from: (i) making any disclosure of relevant and necessary information or documents in any action,
investigation, or proceeding relating to this Agreement, or as required by law or legal process; or (ii) participating, cooperating,
or testifying in any action, investigation, or proceeding with, or reporting possible violations or providing information to, any
governmental agency or legislative body regarding this Agreement or the Company, including, but not limited to, the Company’s
Legal Department, the Securities & Exchange Commission, and/or pursuant to the Dodd-Frank Act (including without limitations
the whistleblower provisions thereof) or Sarbanes-Oxley Act; provided that, other than with respect to providing information to
a governmental agency and to the extent permitted by law, upon receipt of any subpoena, court order or other legal process compelling
the disclosure of any such information or documents, you will give the General Counsel of the Company prompt written notice so
as to permit the Company to protect its interests in confidentiality to the fullest extent possible. Notwithstanding any provision
of this Agreement to the contrary, the provisions of this Agreement are not intended to, and shall be interpreted in a manner that
does not, limit or restrict you from exercising any legally protected whistleblower rights (including pursuant to Rule 21F under
the Securities Exchange Act of 1934, as amended).


 


Upon termination of
your employment or at any time requested by the Company, you will deliver promptly to the Company all memoranda, notes, records,
reports and other documents (whether in paper or electronic form and all copies thereof) relating to the business of the Company
and all other Company property which you obtained or developed while employed by, or otherwise serving or acting on behalf of,
the Company and which you may then possess or have under your control, whether directly or indirectly.


 






    	 	 A-1	 



     


    

 


SENSITIVE


 


Disclosure of Developments and Other
Inventions


 


Without disclosing
any third party confidential information, Employee shall promptly disclose to Company all Developments and any inventions or developments
that Employee believes do not constitute a Development, so that Company can make an independent assessment. Employee represents
and warrants that if Employee developed, conceived or created any Development or other Intellectual Property prior to the date
hereof that relates to Company’s Business, Employee has listed such Intellectual Property on Appendix 1 in a manner that
does not violate any third party rights or disclose any third party confidential information.


 


Ownership of Developments


 


Ownership: All
right, title and interest (including all Intellectual Property rights of any sort throughout the world) relating to any and all
Developments (other than Employee Statutorily Exempt Developments) shall be the exclusive property of Company.


 


Assignment of Rights:
In consideration of Employee’s employment by Company as set forth in the Employment Agreement, Employee hereby assigns to
Company or its designee any and all right, title and/or interest (including all Intellectual Property rights of any sort throughout
the world) in and to any Developments that Employee has or may in the future acquire with respect to any Developments, provided
that this section shall not apply to any Employee Statutorily Exempt Developments.


 


Further Assistance
and Assurances: Employee shall, both during and after his/her employment by Company, at the expense of Company, perform all
lawful acts requested by, or on behalf of, Company to enable Company to obtain, perfect, sustain, and enforce its ownership interest
in any Development(s) in accordance with this Section and to obtain and maintain patents, copyrights and other Intellectual Property
rights for such Development(s) throughout the world.


 


Attorney-In-Fact:
Employee hereby irrevocably designates and appoints Company as Employee’s agent and attorney-in-fact, coupled with an interest
and with full power of substitution, to act for and on Employee’s behalf to execute and file any document and to do all other
lawfully permitted acts to further the purposes of this Section with the same legal force and effect as if executed by Employee.


 


Acknowledgement
of Employee Statutorily Exempt Developments: Employee acknowledges and agrees that, by executing this Agreement, nothing in
this Agreement is intended to expand the scope of protection provided to Employee by Sections 2870 through 2872 of the California
Labor Code or any other statute of like effect. Employee agrees to promptly advise the Company in writing of any developments that
Employee believes may qualify under Sections 2870 through 2872 of the California Labor Code or any other statute of like effect.


 


Records: Employee
agrees to keep and maintain adequate and current records (in the form of notes, sketches, drawings, and in any other form that
may be required by the Company) of all Developments made, written, conceived and/or reduced to practice by Employee during the
period of employment by Company, which records shall be available to and remain the sole property of the Company at all times.


 


Employee IP –
Ownership and Restrictions; License: Any discovery, invention, improvement, computer program and related documentation or other
work that (i) is created during the term of Employee’s employment with the Company and does not fall within the definition
of the term “Development” as defined herein, (ii) is an Employee Statutorily Exempt Development, or (iii) was developed,
created, or conceived prior to Employee’s employment with Company shall, as between Company and Employee, belong to Employee
and shall not be used by Employee in his or her performance on behalf of the Company. Without limiting Company’s other rights
and remedies, if, when acting within the scope of Employee’s employment or otherwise on behalf of Company, Employee uses
or discloses Employee’s own or any third party’s confidential information or other Intellectual Property in violation
of this Agreement (or if any Development cannot be fully made, used, reproduced, distributed and otherwise exploited without using
or violating the foregoing), Employee hereby: (a) grants to Company a perpetual, irrevocable, worldwide, fully-paid, royalty-free,
non-exclusive, sub-licensable right and license to use, exploit and exercise all such confidential information and/or Intellectual
Property rights; and (b) warrants that he/she is entitled to grant such license to the extent the confidential information or Intellectual
Property used by Employee in violation of this Section belongs to a third party.


 






    	 	 A-2	 



     


    

 


SENSITIVE


 


Restrictive Covenants


 


Non-Competition:
During your employment and for a period of one year thereafter (regardless of whether the termination of your employment is voluntary
or involuntary), you will not directly or indirectly (i) engage in, carry on, or provide services (paid or unpaid) whether as a
director, officer, partner, owner, employee, inventor, consultant, advisor, or agent, to any Competitive Business (as defined below)
or (ii) hold any economic interest in any Competitive Business. However, notwithstanding the foregoing, you may own up to five
percent (5%) of the outstanding securities of any publicly traded company and you shall not be prohibited from becoming employed
by, or associated with, a private equity firm or hedge fund (or one of their portfolio companies) that has an investment in a Competitive
Business as long as you have no involvement whatsoever with such Competitive Business (including the formation, planning, or acquisition
of, or investment in, any such Competitive Business).


 


It is not the Company’s
intention to restrict or limit your activities following your termination of employment with the Company unless it is believed
that there is a substantial possibility that your future services or activities in any of the lines of business in which the Company
is engaged may be detrimental to the Company. So as to not unduly restrict your future employment, if you desire to enter into
any employment arrangement or relationship with any potential Competitive Business within the one-year restricted period, please
consult with the Executive Vice President of Human Resources of Arconic/Howmet to discuss your intended relationship with the entity.
Due to the many different businesses in which the Company presently engages, or which in the future the Company may engage, we
will discuss your desire to enter into a business or professional relationship with any manufacturer or firm which is a Competitive
Business. The Company’s consent will not be unreasonably withheld.


 


Also, as a reminder,
Arconic/Howmet stock incentive awards continue to be subject to forfeiture, under the terms of that program, to the extent you
become associated with, employed by, render services to, or own any interest in any business that is in competition with the Company
or if you engage in willful conduct that is injurious to the Company.


 


Non-Solicitation:
During your employment and for a period of one year thereafter (regardless of whether the termination of your employment was voluntary
or involuntary), you will not directly or indirectly (i) solicit, induce or attempt to solicit or induce any employee of the Company
to leave the Company for any reason; (ii) hire or attempt to hire any employee of the Company; or (iii) solicit business from,
or engage in business with, any customer or supplier of the Company that you met and/or dealt with during your employment with
the Company for any purpose. In the event that you become aware that any employee of the Company has been hired by any business
or firm with which you are then affiliated, you will immediately notify the Executive Vice President of Human Resources of Arconic/Howmet
to confirm your non-solicitation of said employee






    	 	 A-3	 



     


    

 


SENSITIVE


 


You acknowledge and
agree that given the nature of the Company’s business, which is conducted throughout the world, the unique and extraordinary
services you will be providing to the Company and your position of confidence and trust with the Company, the scope and duration
of the covenants included in this Agreement (the “Restrictive Covenants”) are reasonable and necessary to protect the
legitimate business interests of the Company. You further acknowledge that you have received substantial consideration from the
Company and that your general skills and abilities are such that you can be gainfully employed in noncompetitive employment, and
that this Agreement will in no way prevent you from earning a living following your employment with the Company.


 


You also recognize
and agree that any breach or threatened or anticipated breach of any part of these Restrictive Covenants will result in irreparable
harm to the Company, and that the remedy at law for any such breach or threatened breach will be inadequate. Accordingly, in addition
to any other legal or equitable remedies that may be available to the Company, you agree that the Company will be entitled to obtain
an injunction, without posting a bond, to prevent any breach or threatened breach of any part of these Restrictive Covenants.


 


In the event that any
court of competent jurisdiction finds that the limitations set forth in these Restrictive Covenants are overly broad with respect
to duration, geographic scope or scope of prohibited activities, such court will have the authority to reduce the duration, area
or activities of such provisions so as to be enforceable to the maximum extent compatible with applicable law, and such provisions
will then be enforced as modified.


 


Notice of Immunity – Defend
Trade Secrets Act of 2016


 


Company employees,
contractors, and consultants may disclose Trade Secrets in confidence, either directly or indirectly, to a Federal, State, or local
government official, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law, or in
a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Additionally, Company
employees, contractors, and consultants who file retaliation lawsuits for reporting a suspected violation of law may disclose related
Trade Secrets to their attorney and use them in related court proceedings, as long as the individual files documents containing
the Trade Secret under seal and does not otherwise disclose the Trade Secret except pursuant to court order.


 


Definitions
for Purposes of this Agreement


 


“Business”
means areas of actual or demonstrably anticipated research and development conducted (or to be conducted) by, or for the benefit
of, Company as well as all products or services sold by, on behalf of, or for the benefit of Company worldwide.


 


“Competitive
Business” means any domestic or international business or firm (including any business in the process of being formed or
planned) that is engaged, or has active plans to become engaged, in any line of business of the Company with which you have had
direct functional accountability, or for which you provided leadership or support, during your last eighteen (18) months of employment
with the Company.


 


“Confidential
Information” includes, but is not limited to strategic plans, trade secrets, inventions, discoveries, technical and operating
know-how, accounting information, product information, marketing and sales data, business strategies, customer information, and
employee data of the Company that is proprietary in nature, and any similar information, data or materials of third parties that
the Company has a duty to keep confidential


 






    	 	 A-4	 



     


    

 


SENSITIVE


 


“Developments”
means all discoveries, inventions, innovations, improvements, computer programs and related documentation, and other works of authorship,
mask works, designs, know-how, ideas and information made, written, conceived and/or reduced to practice, in whole or in part,
(whether or not patentable or subject to other forms of protection) by Employee, individually or with any other person, during
and after the period of Employee’s employment by Company that: (a) relate in any manner to the Business or activities of
Company; and/or (b) are created: (i) at any time using Company resources, including, but not limited to, Company computers, cellphones,
smartphones, etc.; (ii) during working hours; (iii) at a Company facility; (iv) by, or on behalf of, Company; and/or (v) using
Confidential Information.


 


“Employee Statutorily
Exempt Developments” means any Developments which qualify fully under the provisions of any applicable statute (including,
e.g., Section 2870 of the California Labor Code) that prohibits the assignment to Company of Employee’s rights in any inventions
developed entirely on Employee’s own time without using the Company’s equipment, supplies, facilities, resources, trade
secrets or Confidential Information (i.e., excluding inventions that either (i) relate at the time of conception or reduction to
practice of the invention to the Company’s Business, or actual or demonstrably anticipated research or development; or (ii)
result from any work performed by Employee for the Company).


 


“Intellectual
Property” means any intellectual and industrial property and all rights thereof, including, but not limited to, patents,
utility models, semi-conductor topography rights; copyrights, mask works, authors’ rights, registered and unregistered trademarks,
brands, domain names, trade secrets, know-how and other rights in information, drawings, logos, plans, database rights, technical
notes, prototypes, processes, methods, algorithms, any technical-related documentation, any software, registered designs and other
designs, in each case, whether registered or unregistered and including applications for registration, and all rights or forms
of protection having equivalent or similar effect anywhere in the world.


 


Governing Law; Jurisdiction


 


This Agreement will
be governed and interpreted in accordance with the laws of the State of Delaware without reference to its choice of law principles.
Any action arising out of or related to this Agreement will be brought in the state or Federal courts located in Delaware, and
you and the Company consent to the jurisdiction and venue of such courts.


 


Amendment; Waiver


 


No provision of this
Agreement may be modified, waived, or discharged unless such waiver, modification or discharge is in writing. Any failure by you
or the Company to enforce any of the provisions of this Agreement should not be construed to be a waiver of such provisions or
any right to enforce each and every provision in the future. A waiver of any breach of this Agreement will not be construed as
a waiver of any other or subsequent breach.


 


Successors; Binding Agreement


 


Upon the legal separation
of Arconic Corporation from Arconic Inc. (such separation, the “Spinoff”), this Agreement will be assigned to Arconic
Corporation and, from and after the Spinoff, all references herein to “Arconic” shall be deemed to refer to Arconic
Corporation and all references herein to the “Company” shall be deemed to refer to Arconic Corporation collectively
with its subsidiaries, unless the context clearly indicates otherwise.


  






    	 	 A-5	 



     


    

 


The Company has the
right to assign its rights and obligations under this Agreement to any entity that acquires all or substantially all of the assets
of the business for which you work, and continues your employment. The rights and obligations of the Company under this Agreement
will inure to the benefit and be binding upon the successors and assigns of the Company.


 


SENSITIVE


 


Severability


 


In the event that any
one or more of the provisions of this Agreement is held to be invalid, illegal or unenforceable, the validity, legality and enforceability
of the remainder of this Agreement will not in any way be affected or impaired thereby.


 


This Agreement is the
entire agreement between the parties with respect to the matters covered by this Agreement and it replaces all previous agreements,
oral or written, between the parties regarding such matters. PROVISIONS OF THIS AGREEMENT MAY NOT BE WAIVED OR CHANGED EXCEPT BY
A SUBSEQUENT AGREEMENT SIGNED BY YOU AND AN OFFICER OF THE COMPANY.


 


If you agree to the
terms of this Agreement, please sign on the line provided below and return two signed copies. A fully executed copy will be returned
to you for your files after it is signed by the Company.


  


	ARCONIC INC.




 


 


	By:	/s/ Melissa M. Miller 	 




 


 


	AGREED TO AND ACCEPTED AS OF THIS         31st      
  DAY OF        January      , 2020:




 


 


	/s/
    Erick Asmussen	 
	Erick Asmussen	 




 






    	 	 A-6	 



     


    

 


SENSITIVE


 


Appendix 1


 


Prior Employee Inventions 


 






    	 	 A-7